Profile | GDS5420 / 204193_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 2320.74 | 91 |
GSM1296119 | B_lesional_pre-dose | 1070.95 | 80 |
GSM1296076 | C_lesional_pre-dose | 1139.3 | 81 |
GSM1296092 | D_lesional_pre-dose | 1305.46 | 83 |
GSM1296103 | E_lesional_pre-dose | 2419.5 | 91 |
GSM1296078 | F_lesional_pre-dose | 975.01 | 79 |
GSM1296107 | G_lesional_pre-dose | 939.66 | 78 |
GSM1296109 | H_lesional_pre-dose | 1824.19 | 88 |
GSM1296080 | I_lesional_pre-dose | 3645.02 | 95 |
GSM1296090 | J_lesional_pre-dose | 1278.73 | 82 |
GSM1296074 | K_lesional_pre-dose | 1321.23 | 83 |
GSM1296111 | L_lesional_pre-dose | 703.64 | 74 |
GSM1296099 | M_lesional_pre-dose | 1546.03 | 86 |
GSM1296086 | O_lesional_pre-dose | 1242.88 | 82 |
GSM1296117 | P_lesional_pre-dose | 971.44 | 79 |
GSM1296113 | Q_lesional_pre-dose | 951.4 | 79 |
GSM1296096 | R_lesional_pre-dose | 1590.63 | 86 |
GSM1296105 | S_lesional_pre-dose | 2200.86 | 91 |
GSM1296098 | T_lesional_pre-dose | 3406.55 | 95 |
GSM1296101 | U_lesional_pre-dose | 1834.99 | 88 |
GSM1296121 | V_lesional_pre-dose | 1173.64 | 82 |
GSM1296088 | W_lesional_pre-dose | 1704.59 | 87 |
GSM1296082 | X_lesional_pre-dose | 1131.97 | 81 |
GSM1296115 | Y_lesional_pre-dose | 712.38 | 74 |
GSM1296084 | Z_lesional_pre-dose | 1765.76 | 87 |
GSM1296072 | B_lesional_day8 | 1131.94 | 81 |
GSM1296069 | L_lesional_day8 | 932.38 | 78 |
GSM1296071 | P_lesional_day8 | 1186.71 | 82 |
GSM1296070 | Y_lesional_day8 | 943.66 | 78 |
GSM1296073 | V_lesional_day8 | 845.55 | 77 |
GSM1296034 | A_lesional_day15 | 4249.69 | 97 |
GSM1296041 | G_lesional_day15 | 877.19 | 77 |
GSM1296035 | R_lesional_day15 | 2155.39 | 90 |
GSM1296038 | U_lesional_day15 | 1214.38 | 82 |
GSM1296047 | B_lesional_day15 | 1047.61 | 80 |
GSM1296039 | E_lesional_day15 | 1258.87 | 83 |
GSM1296042 | H_lesional_day15 | 1121.57 | 81 |
GSM1296043 | L_lesional_day15 | 849.93 | 77 |
GSM1296037 | M_lesional_day15 | 2206.17 | 90 |
GSM1296046 | P_lesional_day15 | 876.36 | 77 |
GSM1296044 | Q_lesional_day15 | 979.5 | 79 |
GSM1296045 | Y_lesional_day15 | 770.33 | 75 |
GSM1296025 | C_lesional_day15 | 3236.24 | 94 |
GSM1296033 | D_lesional_day15 | 1471.89 | 85 |
GSM1296027 | I_lesional_day15 | 2441.99 | 91 |
GSM1296032 | J_lesional_day15 | 2485.28 | 92 |
GSM1296024 | K_lesional_day15 | 3382.16 | 95 |
GSM1296031 | W_lesional_day15 | 2142 | 90 |
GSM1296028 | X_lesional_day15 | 2068.11 | 90 |
GSM1296029 | Z_lesional_day15 | 2071.43 | 90 |
GSM1296026 | F_lesional_day15 | 2177.77 | 90 |
GSM1296030 | O_lesional_day15 | 2032.03 | 89 |
GSM1296040 | S_lesional_day15 | 2555.82 | 92 |
GSM1296036 | T_lesional_day15 | 2530.06 | 93 |
GSM1296048 | V_lesional_day15 | 1083.42 | 81 |
GSM1296059 | A_lesional_day43 | 1910.94 | 88 |
GSM1296066 | G_lesional_day43 | 794.35 | 76 |
GSM1296060 | R_lesional_day43 | 1838.47 | 88 |
GSM1296063 | U_lesional_day43 | 960.86 | 78 |
GSM1296064 | E_lesional_day43 | 1134.13 | 81 |
GSM1296067 | H_lesional_day43 | 1780.38 | 89 |
GSM1296062 | M_lesional_day43 | 2679.18 | 93 |
GSM1296068 | Q_lesional_day43 | 977.48 | 79 |
GSM1296050 | C_lesional_day43 | 1787.85 | 87 |
GSM1296057 | D_lesional_day43 | 1918.37 | 89 |
GSM1296052 | I_lesional_day43 | 2456.63 | 91 |
GSM1296054 | J_lesional_day43 | 2488.75 | 92 |
GSM1296049 | K_lesional_day43 | 2898.21 | 93 |
GSM1296055 | W_lesional_day43 | 1419.49 | 85 |
GSM1296053 | X_lesional_day43 | 2668.29 | 93 |
GSM1296058 | Z_lesional_day43 | 1907.25 | 88 |
GSM1296051 | F_lesional_day43 | 1421.6 | 84 |
GSM1296056 | O_lesional_day43 | 1842.26 | 87 |
GSM1296065 | S_lesional_day43 | 1410.83 | 84 |
GSM1296061 | T_lesional_day43 | 3138.1 | 95 |
GSM1296095 | A_non-lesional_pre-dose | 1361.97 | 84 |
GSM1296120 | B_non-lesional_pre-dose | 1038.02 | 80 |
GSM1296077 | C_non-lesional_pre-dose | 2585.74 | 92 |
GSM1296093 | D_non-lesional_pre-dose | 2463.2 | 92 |
GSM1296104 | E_non-lesional_pre-dose | 1137.8 | 81 |
GSM1296079 | F_non-lesional_pre-dose | 2204.82 | 90 |
GSM1296108 | G_non-lesional_pre-dose | 914.7 | 78 |
GSM1296110 | H_non-lesional_pre-dose | 1465.81 | 86 |
GSM1296081 | I_non-lesional_pre-dose | 3908.34 | 95 |
GSM1296091 | J_non-lesional_pre-dose | 1399.91 | 84 |
GSM1296075 | K_non-lesional_pre-dose | 1407.87 | 84 |
GSM1296112 | L_non-lesional_pre-dose | 928.82 | 78 |
GSM1296100 | M_non-lesional_pre-dose | 2330.15 | 91 |
GSM1296087 | O_non-lesional_pre-dose | 1396.27 | 84 |
GSM1296118 | P_non-lesional_pre-dose | 1058.95 | 80 |
GSM1296114 | Q_non-lesional_pre-dose | 979.29 | 79 |
GSM1296097 | R_non-lesional_pre-dose | 1634.91 | 86 |
GSM1296106 | S_non-lesional_pre-dose | 1651.55 | 87 |
GSM1296102 | U_non-lesional_pre-dose | 2156.87 | 91 |
GSM1296122 | V_non-lesional_pre-dose | 1424.63 | 85 |
GSM1296089 | W_non-lesional_pre-dose | 1578.2 | 86 |
GSM1296083 | X_non-lesional_pre-dose | 3251.02 | 94 |
GSM1296116 | Y_non-lesional_pre-dose | 874.09 | 77 |
GSM1296085 | Z_non-lesional_pre-dose | 2020.5 | 89 |